SF
MYOV

Synovus Financial’s Myovant Sciences Ltd. MYOV Stock Holding History

Synovus Financial’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-158,017
Closed -$2.84M – 903
2022
Q3 		$2.84M Sell
158,017
-5,115
-3% -$81.7K 0.03% 256
2022
Q2 		$2.03M Buy
163,132
+7,956
+5% +$87.8K 0.02% 313
2022
Q1 		$2.07M Buy
155,176
+61,821
+66% +$829K 0.02% 319
2021
Q4 		$1.45M Buy
93,355
+6,919
+8% +$132K 0.01% 382
2021
Q3 		$1.94M Sell
86,436
-2,384
-3% -$52.3K 0.02% 319
2021
Q2 		$2.02M Buy
88,820
+11,030
+14% +$232K 0.02% 304
2021
Q1 		$1.59M Buy
77,790
+13,508
+21% +$308K 0.02% 306
2020
Q4 		$1.78M Buy
64,282
+4,960
+8% +$96.5K 0.02% 295
2020
Q3 		$836K Buy
59,322
+956
+2% +$17.8K 0.01% 374
2020
Q2 		$1.2M Buy
+58,366
New +$794K 0.02% 300

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Synovus Financial's MYOV Position: Q4 2022 in Review

Synovus Financial sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 158,017 shares — an estimated $2.84M sold.

Synovus Financial first reported a position in MYOV in Q2 2020 and held it in 10 quarters. The position peaked at $2.84M in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Synovus Financial reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Synovus Financial sold 158,017 Myovant Sciences Ltd. shares in Q4 2022, an estimated $2.84M.
  • Synovus Financial first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 10 quarters.
  • Synovus Financial's Myovant Sciences Ltd. position peaked at $2.84M in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Synovus Financial's 13F filing for Q4 2022, filed 6 Feb 2023.